Stockreport

Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $524 millionEC and U.S. FDA label updates for CARVYKTI® to include overall survival ben [Read more]